Literature DB >> 21193339

Impact of rotavirus vaccination on childhood deaths from diarrhea in Brazil.

Tatiana M Lanzieri1, Alexandre C Linhares, Iolanda Costa, Devayani A Kolhe, Maria Helena Cunha, Eduardo Ortega-Barria, Romulo E Colindres.   

Abstract

OBJECTIVES: Rotavirus vaccination was introduced in Brazil in March 2006, targeting an annual birth cohort of approximately 3.5 million. We analyzed trends in all-cause gastroenteritis-related deaths in children <5 years of age during the pre- and post-vaccination periods.
METHODS: Data from the National Immunization Program and the Mortality Information System were used to calculate vaccine coverage and mortality rates related to gastroenteritis in children <1 year and 1-4 years of age, using population estimates from the census as the denominator. Relative reductions in mortality rates were calculated for 2007 and 2008, using the 2004-2005 mean as baseline before vaccine introduction.
RESULTS: Coverage of two doses of human rotavirus vaccine was 39% in 2006, increasing to 72% in 2007 and 77% in 2008. During 2004-2005, the gastroenteritis mortality rate in children <1 year of age was 56.9 per 100 000, decreasing by 30% (95% confidence interval (CI) 19-41) in 2007 and by 39% (95% CI 29-49) in 2008. In children 1-4 years of age, the mortality rate was 4.5 per 100 000 during 2004-2005, decreasing by 29% (95% CI 10-49) in 2007 and by 33% (95% CI 15-52) in 2008.
CONCLUSIONS: The decreased rates of childhood gastroenteritis-related deaths in Brazil following rotavirus vaccine introduction, particularly among children <1 year of age, suggest the potential benefit of vaccination.
Copyright © 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21193339     DOI: 10.1016/j.ijid.2010.11.007

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  16 in total

Review 1.  Rotavirus vaccines: current status and future considerations.

Authors:  Catherine Yen; Jacqueline E Tate; Terri B Hyde; Margaret M Cortese; Benjamin A Lopman; Baoming Jiang; Roger I Glass; Umesh D Parashar
Journal:  Hum Vaccin Immunother       Date:  2014-04-22       Impact factor: 3.452

2.  Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine, Rotarix: approach and outcome.

Authors:  Gary Dubin; Jean-François Toussaint; Jean-Pol Cassart; Barbara Howe; Donna Boyce; Leonard Friedland; Remon Abu-Elyazeed; Sylviane Poncelet; Htay Htay Han; Serge Debrus
Journal:  Hum Vaccin Immunother       Date:  2013-08-28       Impact factor: 3.452

3.  Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines.

Authors:  N Aliabadi; J E Tate; U D Parashar
Journal:  Clin Microbiol Infect       Date:  2016-04-26       Impact factor: 8.067

Review 4.  The global problem of childhood diarrhoeal diseases: emerging strategies in prevention and management.

Authors:  Margaret Mokomane; Ishmael Kasvosve; Emilia de Melo; Jeffrey M Pernica; David M Goldfarb
Journal:  Ther Adv Infect Dis       Date:  2017-12-07

Review 5.  Rotavirus vaccine and diarrhea mortality: quantifying regional variation in effect size.

Authors:  Christa L Fischer Walker; Robert E Black
Journal:  BMC Public Health       Date:  2011-04-13       Impact factor: 3.295

6.  Diarrhea and health inequity among Indigenous children in Brazil: results from the First National Survey of Indigenous People's Health and Nutrition.

Authors:  Ana Lúcia Escobar; Carlos E A Coimbra; James R Welch; Bernardo L Horta; Ricardo Ventura Santos; Andrey M Cardoso
Journal:  BMC Public Health       Date:  2015-02-27       Impact factor: 3.295

7.  The prevalence of norovirus, astrovirus and adenovirus infections among hospitalised children with acute gastroenteritis in Porto Velho, state of Rondônia, western Brazilian Amazon.

Authors:  Maria Sandra Costa Amaral; Grecy Kelli Estevam; Marilene Penatti; Roger Lafontaine; Ian Carlos Gomes Lima; Paula Katharine Pontes Spada; Yvone Benchimol Gabbay; Najla Benevides Matos
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-03-06       Impact factor: 2.743

8.  Reactogenicity and safety of a liquid human rotavirus vaccine (RIX4414) in healthy adults, children and infants in China: randomized, double-blind, placebo-controlled Phase I studies.

Authors:  Rong-Cheng Li; Yan-Ping Li; Zhao-Jun Mo; Dong Luo; Teng Huang; Ji-Lian Kong; Lao-Hong Wang; Ning-Sheng Song; Aixue Liu; Helen Zhang; Xueyan Liao; Naveen Karkada; Htay Htay Han
Journal:  Hum Vaccin Immunother       Date:  2013-06-04       Impact factor: 3.452

9.  Removing the age restrictions for rotavirus vaccination: a benefit-risk modeling analysis.

Authors:  Manish M Patel; Andrew D Clark; Colin F B Sanderson; Jacqueline Tate; Umesh D Parashar
Journal:  PLoS Med       Date:  2012-10-23       Impact factor: 11.069

10.  The human rotavirus vaccine Rotarix™ in infants: an integrated analysis of safety and reactogenicity.

Authors:  Hubert Buyse; Carlota Vinals; Naveen Karkada; Htay Htay Han
Journal:  Hum Vaccin Immunother       Date:  2013-10-08       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.